Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live
Business corporate update

DataMEDS AI Launches New Corporate Website

Analysis based on 7 articles · First reported Sep 21, 2026 · Last updated Sep 21, 2026

Sentiment
5
Attention
1
Articles
7
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard

The website launch is a minor corporate communications event with negligible immediate impact on DataMeds AI's stock or the broader market, as it discloses no new financial results or material transactions. Investor attention will likely remain focused on the previously announced Helomics acquisition, the litigation settlement, and the pending multi-party transaction involving Datavault AI, Scilex Holding Company, EOS Holdings and HealthBridge Advisors.

health information technology pharmacy telemedicine

DataMeds AI, Inc. (NASDAQ:MEDS), a Tampa-based Health IT company formerly known as Wellgistics, Inc., announced on September 21, 2026 the launch of its new corporate website, www.DataMedsAI.com. The company said the updated site aligns with pending marketing initiatives and reflects its new AI-centric branding following the recent closing of its acquisition of Helomics Corporation's artificial intelligence Cancer Diagnostics Lab from Axe Compute, and the settlement of outstanding litigation that extinguished approximately $19 million in liabilities and retired 364,099 common shares. Interim Co-CEO Gerald Commissiong stated that with the Helomics acquisition closed and litigation related to the May 11, 2023 acquisition of Wellgistics, LLC settled, the company is poised to launch its Health Lives Here consumer application and intends to soft launch the app in short order. DataMEDS describes itself as vertically integrating technology, pharmacy, pharmaceutical-adjacent and telemedicine business units, incorporating the EinsteinRx artificial intelligence platform and the PharmacyChain blockchain-enabled smart contracts platform into the Health Lives Here mobile application, while its Corexa Health subsidiary provides pharmacy and pharmacy services, including distribution of products developed by Tollo Health. The press release also references a proposed transaction with Datavault AI Inc. (NASDAQ:DVLT), Scilex Holding Company, EOS Holdings and HealthBridge Advisors, subject to closing conditions and stockholder approval. The announcement is a routine corporate communications update with no direct financial figures disclosed beyond the previously reported liability extinguishment and share retirement.

70 DataMeds AI acquired Helomics
65 DataMeds AI settled outstanding litigation
40 DataMeds AI launched new website
priv
DataMeds AI is the central actor, launching its new corporate website as part of rebranding and marketing efforts following its Helomics acquisition and litigation settlement. The update is largely promotional and does not materially change its financial position.
Importance 100.0 Sentiment 10.0
priv
Helomics' AI Cancer Diagnostics Lab was acquired by DataMeds AI from Axe Compute, and the completed deal is cited as a driver of the company's new branding and website launch.
Importance 40.0 Sentiment 5.0
per
Gerald Commissiong, Interim Co-CEO of DataMeds AI, commented on the website launch, the Helomics acquisition closing, the litigation settlement, and plans to soft launch the Health Lives Here app.
Importance 30.0 Sentiment 0.0
priv
Axe Compute was the seller of Helomics Corporation's AI Cancer Diagnostics Lab to DataMeds AI, a transaction now closed and referenced in the website launch announcement.
Importance 20.0 Sentiment 0.0
priv
Wellgistics is the former name of DataMeds AI, and litigation related to its May 11, 2023 acquisition was settled, removing liabilities from the balance sheet.
Importance 15.0 Sentiment 0.0
priv
Datavault AI is named as a counterparty in a proposed transaction with DataMeds AI mentioned in forward-looking statements, with no new details disclosed.
Importance 10.0 Sentiment 0.0
stock
Scilex Holding Company is listed as a party to a proposed transaction with DataMeds AI referenced in the press release, with no new developments reported.
Importance 10.0 Sentiment 0.0
priv
Corexa Health is DataMeds AI's subsidiary providing pharmacy and pharmacy services, mentioned as part of the company's business description.
Importance 10.0 Sentiment 0.0
priv
EOS Holdings is mentioned as a participant in a proposed transaction with DataMeds AI, with no new information provided in this announcement.
Importance 8.0 Sentiment 0.0
priv
HealthBridge Advisors is named as a party to a proposed transaction with DataMeds AI, referenced only in forward-looking statements.
Importance 8.0 Sentiment 0.0
priv
Tollo Health develops products distributed by DataMeds AI's Corexa Health subsidiary, noted in the company background.
Importance 8.0 Sentiment 0.0
exch
Nasdaq is the exchange where DataMeds AI (MEDS) and Datavault AI (DVLT) are listed, and compliance with Nasdaq listing standards is referenced in forward-looking statements.
Importance 5.0 Sentiment 0.0
DataMeds AI parent ↔ Corexa Health DataMeds AI is the parent company that established Corexa Health as its pharmacy-focused division, leveraging its networ
Datavault AI licensor, investee ↔ Scilex Holding Company Datavault AI licenses its AI-driven technology to Scilex for a Biotech Exchange platform and receives strategic investme
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.